Skip to content
Saturday, June 14, 2025
Latest:
  • 2025 Echo Board Review Course
  • Harvard Innovations and New Practices in Internal Medicine 2025
  • The Brigham Board Review and Comprehensive Update in Endocrinology 2025
  • UW Medicine Comprehensive Hematology & Oncology Review 2024
  • The PassMachine Internal Medicine Board Review Course 2024 (+QBank)
Medicine Academy | USMLE & Board Videos

More results...

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
MENUMENU
  • REFUND POLICY
  • Specialities
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Endocrinology
    • Emergency Medicine
    • Gastroenterology
    • Family Medicine
    • Hematology
    • Infectious disease
    • Internal Medicine
    • Surgery
    • Neurology
    • Nephrology
    • Obstetrics and Gynecology
    • Rheumatology
    • Radiology
    • Oncology
    • Pathology
    • Pediatrics
    • Pulmonology
  • USMLE
    • Boards And Beyond
    • Doctors in Training
    • Draw it to know it
    • Kaplan
    • Lecturio
    • Medquest
    • Sketchy
  • Qbank
  • FAQ
  • How to Buy
  • Terms
BoardPathologyUSCAP

USCAP Myeloproliferative and Myelodysplastic Neoplasms: The Past, Present, and Future

November 8, 2024 admin

 

Course Description
In the era of the rapid development of new diagnostic modalities and novel targeted treatment options, a comprehensive diagnostic approach to myelodysplastic and myeloproliferative neoplasms becomes ever more critical. However, the rapidly evolving scientific and technological discoveries that have been continuously incorporated into the classification of myelodysplastic and/or myeloproliferative neoplasms significantly increase already complex hematopathology practice. (Hemato)pathologists are currently facing the following challenges:

  • How to stay abreast of this avalanche of data?
  • How to incorporate the data into my day-to-day practice?
  • What testing should I order to correctly classify myelodysplastic and myeloproliferative neoplasms?
  • How should my diagnosis be worded in the face of two new classifications of hematologic neoplasms (5th edition WHO and 2022 International Consensus Classifications).

This course, led by four experienced academic hematopathologists practicing at four large cancer centers, will answer all of these questions (and more) by reviewing cases of myeloid neoplasms with myelodysplastic and myeloproliferative features. Join us on the exciting journey from the past to the present and into the future!

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:

  • Become familiar with the changes to classification of myelodysplastic and myeloproliferative neoplasms and overlap myelodysplastic/myeloproliferative neoplasms.
  • Identify critical ancillary testing needed for accurate classification, as informed by the clinical scenario or morphologic findings.
  • Recognize morphologic and immunophenotypic correlates of underlying genetic lesions in MDS/MPN and related neoplasms.
  • Generate a comprehensive (and comprehensible), clinically relevant, integrated pathology report that includes the most updated classification systems.

Details : 8 MP4 + 7 PDF files

Price : $ 150

Buy

  • USCAP Crash Course in Cytopathology: Thorax, Soft Tissue, Head and Neck, Liver, Pancreatobiliary and Genitourinary Tract
  • USCAP Bone and Soft Tissue Pathology: Keep Calm and Navigate the Updates and Pitfalls

You May Also Like

Radiology Subspecialty Case Review – ARRS 2024

January 31, 2025 admin

HIPPO Essentials of Emergency Medicine 2022

August 8, 2022 admin

CHEST : Pediatric Pulmonary Board Review On Demand 2020

November 30, 2020 admin
Copyright © 2025 Medicine Academy | USMLE & Board Videos. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.